Antithrombin use during pediatric cardiac extracorporeal membrane oxygenation admission: insights from a national database.

CONCLUSION: Antithrombin administration is associated with increased mortality, a shorter length of stay, and decreased billing cost. Recently, antithrombin usage has been decreasing-potentially due to the reported lack of clinical benefit. Together, these results reinforce that antithrombin may not be indicated for all pediatric extracorporeal membrane oxygenation patients. PMID: 32650697 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32650697?dopt=Abstract

Source: Perfusion - July 9, 2020 Category: Cardiovascular & Thoracic Surgery Authors: Aiello SR, Flores S, Coughlin M, Villarreal EG, Loomba RS Tags: Perfusion Source Type: research